Comparison between Neostigmine and conventional method for treatment of Post Dural Puncture Headache

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201510001299332

Enrollment

110

Registered

2015-10-09

Start date

2014-03-26

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post dural puncture headache Anaesthesia

Interventions

neostigmine

conventional method

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - age:21 to 50 years - post dural puncture headache

Exclusion criteria

Exclusion criteria: - age less than 21 years or more than 50 years - suspected other cause of headache e.g. migraine - allergy to neostigmine - contraindicated atropine e.g. glucoma

Design outcomes

Primary

Measure	Time frame
treatment of post dural puncture headache	—

Secondary

Measure	Time frame
absent recurrence of headache	—

Countries

Egypt

Contacts

Public ContactAhmed Abdelaal Ahmed Mahmoud

lecturer of anesthesiology, faculty of medicine, Beni Suef University

carnitin7@yahoo.com00201113308866

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026